News

Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales26.0233.38 -22 110.44103.84 6 OPM %12.4113.69 -15.4018.24 - PBDT2.654.43 -40 14.8217.63 -16 PBT2.383.87 -39 13.9216.53 -16 NP1.973.68 -46 13.1216.27 -19 Powered by Capital Market - Live News

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Indo US Bio-Tech declined 40.59% to Rs 3.00 crore in the quarter ended December 2025 as against Rs 5.05 crore during the previous quarter ended December 2024. Sales declined 3.23% to Rs 22.80 crore in the quarter ended December 2025 as against Rs 23.56 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.8023.56 -3 OPM %18.2023.47 - PBDT3.395.17 -34 PBT3.175.01 -37 NP3.005.05 -41 Powered by Capital Market - Live News

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 October 2025.Powered by Capital Market - Live News